Home / Treatments / Stent

Stent denials: what the review data shows

Independent reviewers have decided 23 published cases where an insurer denied Stent — and they overturned the insurer 69.6% of the time. A denial for Stent is a starting position, not a final answer.

Published decisions
23
2001–2026
Overturned
69.6%
16 denials reversed

Conditions behind stent denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Coronary Artery Disease4
75%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
12
66.7%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
11
72.7%
Typical time to a decision
8 days
Most land between 5 and 21 days
Handled as urgent
56.5%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/ Case Summary: The enrollee is requesting reimbursement for a stent and percutaneous transcatheter placement of drug eluting intracoronary stent done. The enrollee initially presented to his physician with complaints of chest pain on exertion. The left sided chest pain has been ongoing for the past days, and he had similar pains in past. The pain radiated to his left scapula and he has had recurrence of several episodes of chest discomfort with exertion. Findings the physician reviewer found that after a one to two min rest after onset of the pain, it resolves. He says that all episodes are under heavy exertion, backpack at high altitudes. He does not have a personal history of heart disease, but his father had coronary artery disease with a cardiac bypass. He had two routine visits and had no complaint of chest pain.
Medical Necessity · 2019 · IMR MN19-31222
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for extracranial carotid artery stenting (CAS). Per the available records, this patient is a high surgical risk to undergo CEA because he has bilateral carotid stenosis with left- and right-sided occlusion. This supports that the patient is at high-risk to undergo CEA. Moreover, there are adequate data supporting a role for CAS in this patient’s clinical setting. Overall, CAS is a reasonable alternative to CEA in select patients with high-grade asymptomatic stenosis or symptomatic carotid stenosis.
Experimental/Investigational · 2023 · IMR EI23-38827

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for endovascular stenting.Nutcracker syndrome is a condition that is relatively rare, with few providers having significant hands-on experience. Medical literature on the subject of nutcracker syndrome is mainly based on case reports and small case series. Due to this limited experience, there are no established guidelines regarding this condition. There are, however, generally accepted indications and treatment options. Generally accepted indications for treatment include flank pain, particularly on the left side, hematuria either gross or microscopic (not absolutely required), evidence of renal vein compression by imaging studies including CT scan, and evidence of vascular engorgement.
Medical Necessity · 2019 · IMR MN19-32072
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a coronary angiogram with stent placement. Per the medical records, the patient has coronary artery disease without evidence of flow limitation by symptoms or by stress echocardiogram. While computed tomography fractional flow reserve (CT-FFR) results were noted as abnormal, this method of measuring FFR is not well studied. In this case, there is either no ischemia due to lack of flow limitation or stable silent ischemia in the mid-left anterior descending (LAD) territory with a false negative stress test. In either of these scenarios, revascularization with coronary stenting has not been shown to improve outcome compared to standard medical therapy alone and is not recommended according to the current guidelines.
Experimental/Investigational · 2025 · IMR EI25-44497

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Stentwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Stent? 69.6% got it reversed.

Explain my denial — freeStart my appeal · $39